206 related articles for article (PubMed ID: 21870058)
1. Correlation of SATB1 overexpression with the progression of human rectal cancer.
Meng WJ; Yan H; Zhou B; Zhang W; Kong XH; Wang R; Zhan L; Li Y; Zhou ZG; Sun XF
Int J Colorectal Dis; 2012 Feb; 27(2):143-50. PubMed ID: 21870058
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression.
Shen Z; Zeng Y; Guo J; Wu Y; Jiang X; Ding R; Wu C; Li R; Luo B; Zeng C; Jiang H; Jie W
J Transl Med; 2013 Sep; 11():217. PubMed ID: 24047082
[TBL] [Abstract][Full Text] [Related]
3. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population.
Lu X; Cheng C; Zhu S; Yang Y; Zheng L; Wang G; Shu X; Wu K; Liu K; Tong Q
Oncol Rep; 2010 Oct; 24(4):981-7. PubMed ID: 20811679
[TBL] [Abstract][Full Text] [Related]
4. Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues.
Kowalczyk AE; Godlewski J; Krazinski BE; Kiewisz J; Sliwinska-Jewsiewicka A; Kwiatkowski P; Pula B; Dziegiel P; Janiszewski J; Wierzbicki PM; Kmiec Z
Tumour Biol; 2015 Jun; 36(6):4441-52. PubMed ID: 25874491
[TBL] [Abstract][Full Text] [Related]
5. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of SATB1 is associated with the development and progression of glioma.
Chu SH; Ma YB; Feng DF; Zhang H; Zhu ZA; Li ZQ; Jiang PC
J Transl Med; 2012 Jul; 10():149. PubMed ID: 22839214
[TBL] [Abstract][Full Text] [Related]
7. Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer.
Meng WJ; Pathak S; Ding ZY; Zhang H; Adell G; Holmlund B; Li Y; Zhou ZG; Sun XF
Cancer Biol Ther; 2015; 16(12):1738-45. PubMed ID: 26528635
[TBL] [Abstract][Full Text] [Related]
8. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
9. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract][Full Text] [Related]
10. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
[TBL] [Abstract][Full Text] [Related]
11. SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.
Zhang J; Zhang B; Zhang X; Sun Y; Wei X; McNutt MA; Lu S; Liu Y; Zhang D; Wang M; Lin Z; Niu N
PLoS One; 2013; 8(1):e47902. PubMed ID: 23326301
[TBL] [Abstract][Full Text] [Related]
12. [Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance].
Liu CX; Wen Y; Xu K; Zheng SB; Xu YW; Chen BS
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1389-91, 1394. PubMed ID: 20584685
[TBL] [Abstract][Full Text] [Related]
13. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
14. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.
Fang XF; Hou ZB; Dai XZ; Chen C; Ge J; Shen H; Li XF; Yu LK; Yuan Y
World J Gastroenterol; 2013 Apr; 19(15):2331-9. PubMed ID: 23613626
[TBL] [Abstract][Full Text] [Related]
15. Pilot study special AT-rich sequence-binding protein 1 investigating as a potential biomarker for esophageal squamous cell carcinoma.
Cong QX; Zhang H; Sun SX; Li HF; Wang Y; Jian S
Dis Esophagus; 2016 Aug; 29(6):621-6. PubMed ID: 25951709
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma.
Cheng C; Wan F; Liu L; Zeng F; Xing S; Wu X; Chen X; Zhu Z
PLoS One; 2014; 9(5):e97406. PubMed ID: 24835085
[TBL] [Abstract][Full Text] [Related]
17. Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines.
Gnosa S; Shen YM; Wang CJ; Zhang H; Stratmann J; Arbman G; Sun XF
J Transl Med; 2012 May; 10():109. PubMed ID: 22643064
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated SATB1 is associated with the progression and prognosis of glioma.
Han S; Xia J; Qin X; Han S; Wu A
Cell Death Dis; 2013 Oct; 4(10):e901. PubMed ID: 24176859
[TBL] [Abstract][Full Text] [Related]
19. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SATB1 in laryngeal squamous cell carcinoma.
Zhao XD; Ji WY; Zhang W; He LX; Yang J; Liang HJ; Wang LL
ORL J Otorhinolaryngol Relat Spec; 2010; 72(1):1-5. PubMed ID: 20110741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
